Validation from big pharma would be nice and probably would have an immediate and dramatic effect on the share price.  But at what cost to the future share price due to shared future revenues?

Epigenetic Experts: We probably have the best experts on the planet in this new science of epigenetics that they are leaders in. 

Scientific Validation:  We should have enough validation from the FDA with the Breakthrough Therapy Designation and also proven long-term use safety profile.  

Clinical Trial Expertise:  We have some experience and we now have the full attention and assistance of the FDA in guiding the planning and running of the next trial.

JMHO